|Articles|January 15, 2007
FreshKote gets EU approval
Aqueous Pharma has received European Union approval for its three layered artificial tear formula for dry eye, FreshKote.
Advertisement
Aqueous Pharma has received European Union approval for its three layered artificial tear formula for dry eye, FreshKote.
The approval comes after the formula was granted the CE Mark. FreshKote is now approved for sale in all 25 countries of the EU and was also recently launched in the United States.
The FreshKote formula is patent pending.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















